Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Dallah Healthcare Co's Enterprise Value is ﷼14,444 Mil.
Dallah Healthcare Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ﷼-68 Mil. Therefore, Dallah Healthcare Co's EV-to-FCF for today is -212.05.
The historical rank and industry rank for Dallah Healthcare Co's EV-to-FCF or its related term are showing as below:
SAU:4004'
s EV-to-FCF Range Over the Past 10 Years
Min: -328.16 Med: 54.29 Max: 961.73
Current: -215.02
During the past 13 years, the highest EV-to-FCF of Dallah Healthcare Co was 961.73. The lowest was -328.16. And the median was 54.29.
SAU:4004's EV-to-FCF is ranked worse than 100% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 18.06
vs SAU:4004: -215.02
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Dallah Healthcare Co (SAU:4004) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Dallah Healthcare Co's PE Ratio (TTM) for today is calculated as:
Dallah Healthcare Co's share price for today is ﷼104.50.
Dallah Healthcare Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼4.570.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Dallah Healthcare Co EV-to-FCF Related Terms
Dallah Healthcare Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Dallah Healthcare Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Dallah Healthcare Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dallah Healthcare Co EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Dallah Healthcare Co's EV-to-FCF falls into.
Dallah Healthcare Co's current Enterprise Value is ﷼14,444 Mil.
Dallah Healthcare Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼-68 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dallah Healthcare Co (SAU:4004) has a EV-to-FCF of -212.05 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Dallah Healthcare Co and its competitors. According to the industry distribution chart, Dallah Healthcare Co ranks #999999 out of 405 companies in the Healthcare Providers & Services industry.
Is Dallah Healthcare Co's EV-to-FCF too high?
Dallah Healthcare Co's current EV-to-FCF is -212.05. Based on the distribution chart, Dallah Healthcare Co ranks #999999 out of 405 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Dallah Healthcare Co has a GF Score™ of 93/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dallah Healthcare Co ranks #999999 out of 405 companies for EV-to-FCF. This places Dallah Healthcare Co in the lower half of its industry. The industry median EV-to-FCF is 18.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.06, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Dallah Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dallah Healthcare Co's current EV-to-FCF is -212.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼206.30, compared to a current price of ﷼104.50 — trading 49.3% below its estimated fair value. The current EV-to-FCF is -212.05. Dallah Healthcare Co's overall GF Score™ is 93/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current EV-to-FCF is -212.05 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?
Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued.
The current stock price of ﷼104.50 is trading 49.3% below its estimated GF Value™ of ﷼206.30.
GuruFocus considers Dallah Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4004:
EV-to-FCF: -212.05
GF Value™: ﷼206.30 vs. price of ﷼104.50 (49.3% below fair value)
No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
93GF Score
Get the complete analysis for SAU:4004
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4004 has been successfully added to your 
